MedTrace Logo

Treatment of Severe Depressive Illness by Targeted Brain Surgery

NCT01101373 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2019-11-19

No results posted yet for this study

Summary

This study will report on the outcome of a clinical program, operational since 1998, that has used surgery targeting an emotional pathway in the brain in the treatment of severe depressive illness that has failed to respond to all other available interventions. Benefit from surgery was anticipated on the basis that the lesion (bilateral anterior capsulotomy) is a well established surgical target for treating severe treatment resistant depression.

Conditions

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Christopher Honey, MD · University of British Columbia

  • Judy Allen, MD · University of British Columbia

  • Robert Hewko, MD · University of British Columbia

  • Caroline Gosselin, MD · University of British Columbia

  • Nicolas Bogod, MD · University of British Columbia

  • Jeff Martzke, MD · University of British Columbia

  • Patricia Taylor · University of British Columbia

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Primary Completion
2009-11-30
Completion
2010-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101373 on ClinicalTrials.gov